Company intelligence / Profile preview

Hanhui Pharmaceutical

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Hanhui Pharmaceutical operates a leading GMP/FDA/EU-certified manufacturing site in Hangzhou. The site passed US FDA audits multiple years with no defects, and is used for technology transfers of innovator medicines from Pfizer and other multinationals. It has successfully localized multiple innovator products (e.g. minocycline hydrochloride capsules, piperacillin sodium+tazobactam sodium for injection, amlodipine besylate, atorvastatin calcium, and others, many listed in National Procurement Catalog).

Therapeutic areas: ImmunologyEndocrinologyHematologyOncologyNeurology
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

Pfizer (technology transfer, supply chain)Hillhouse Capital (previous equity transaction, continuing tech transfer)

Beyond the preview

Go deeper on Hanhui Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hanhui Pharmaceutical.

Explore the full profile